Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Valeo Pharma Inc (OP: VPHIF )

0.1050 UNCHANGED
Last Price Updated: 11:23 AM EDT, Apr 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.1050
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1050
Today's Range 0.1050 - 0.1050
52wk Range 0.1000 - 0.4274
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CORRECT AND REPLACE: Valeo Pharma CEO credits Enerzair for strong position on Canada’s top-growing companies list
--News Direct-- 
Via News Direct
CORRECT AND REPLACE: Valeo Pharma CEO credits Enerzair for strong position on Canada’s top-growing companies list
Valeo Pharma Inc. (TSX:VPH, OTCQB:VPHIF) CEO Steve Saviuk joined Proactive's Stephen Gunnion to discuss the company's strong position on the Globe and Mail's Report on Business annual list of Canada’s... 
Via TheNewswire.com

Performance

YTD
-23.53%
-23.53%
1 Month
-22.11%
-22.11%
3 Month
-58.66%
-58.66%
6 Month
+5.00%
+5.00%
1 Year
-71.25%
-71.25%

More News

Read More
Valeo Pharma CEO credits Enerzair for strong position on Canada’s top-growing companies list
Via News Direct
Valeo Pharma CEO credits Enerzair for strong position on Canada’s top-growing companies list
Via TheNewswire.com
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
Life Sciences Virtual Investor Forum Agenda Announced for March 9th
From Virtual Investor Conferences
Via GlobeNewswire
Valeo Pharma to Webcast Live at VirtualInvestorConferences.com March 9th
From Virtual Investor Conferences
Via GlobeNewswire
7 Penny Stocks to Buy as a New Bull Market Emerges
Via InvestorPlace
5 Under-the-Radar Penny Stocks With 100% Upside Potential
Via InvestorPlace
Valeo Pharma Ceo Interview on RICH TV LIVE
Via TheNewswire.com
The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout
Via Benzinga
Pharma Companies Seeking to Improve Health Outcomes With Innovative Products
Via FinancialNewsMedia
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.